Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development

Background: Colorectal cancers are characterized by genetic and epigenetic alterations. This study aimed to explore the timing of promoter methylation and relationship with mutations and chromosomal alterations in colorectal carcinogenesis. Methods: In a series of 47 nonprogressed adenomas, 41 progr...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Derks, Cindy Postma, Peter T. M. Moerkerk, Sandra M. van den Bosch, Beatriz Carvalho, Mario A. J. A. Hermsen, Walter Giaretti, James G. Herman, Matty P. Weijenberg, Adriaan P. de Bruïne, Gerrit A. Meijer, Manon van Engeland
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2006/846251
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549233439277056
author Sarah Derks
Cindy Postma
Peter T. M. Moerkerk
Sandra M. van den Bosch
Beatriz Carvalho
Mario A. J. A. Hermsen
Walter Giaretti
James G. Herman
Matty P. Weijenberg
Adriaan P. de Bruïne
Gerrit A. Meijer
Manon van Engeland
author_facet Sarah Derks
Cindy Postma
Peter T. M. Moerkerk
Sandra M. van den Bosch
Beatriz Carvalho
Mario A. J. A. Hermsen
Walter Giaretti
James G. Herman
Matty P. Weijenberg
Adriaan P. de Bruïne
Gerrit A. Meijer
Manon van Engeland
author_sort Sarah Derks
collection DOAJ
description Background: Colorectal cancers are characterized by genetic and epigenetic alterations. This study aimed to explore the timing of promoter methylation and relationship with mutations and chromosomal alterations in colorectal carcinogenesis. Methods: In a series of 47 nonprogressed adenomas, 41 progressed adenomas (malignant polyps), 38 colorectal carcinomas and 18 paired normal tissues, we evaluated promoter methylation status of hMLH1, O6MGMT, APC, p14ARF, p16INK4A, RASSF1A, GATA-4, GATA-5, and CHFR using methylation-specific PCR. Mutation status of TP53, APC and KRAS were studied by p53 immunohistochemistry and sequencing of the APC and KRAS mutation cluster regions. Chromosomal alterations were evaluated by comparative genomic hybridization. Results: Our data demonstrate that nonprogressed adenomas, progressed adenomas and carcinomas show similar frequencies of promoter methylation for the majority of the genes. Normal tissues showed significantly lower frequencies of promoter methylation of APC, p16INK4A, GATA-4, and GATA-5 (P-values: 0.02, 0.02, 1.1×10−5 and 0.008 respectively). P53 immunopositivity and chromosomal abnormalities occur predominantly in carcinomas (P values: 1.1×10−5 and 4.1×10−10). Conclusions: Since promoter methylation was already present in nonprogressed adenomas without chromosomal alterations, we conclude that promoter methylation can be regarded as an early event preceding TP53 mutation and chromosomal abnormalities in colorectal cancer development.
format Article
id doaj-art-6197e484961441bebbc8ce10a2d9e3e8
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-6197e484961441bebbc8ce10a2d9e3e82025-02-03T06:11:45ZengWileyCellular Oncology1570-58701875-86062006-01-01285-624725710.1155/2006/846251Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer DevelopmentSarah Derks0Cindy Postma1Peter T. M. Moerkerk2Sandra M. van den Bosch3Beatriz Carvalho4Mario A. J. A. Hermsen5Walter Giaretti6James G. Herman7Matty P. Weijenberg8Adriaan P. de Bruïne9Gerrit A. Meijer10Manon van Engeland11Department of Pathology, Research Institute GROW, University Maastricht, The NetherlandsDepartment of Pathology, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Pathology, Research Institute GROW, University Maastricht, The NetherlandsDepartment of Pathology, Research Institute GROW, University Maastricht, The NetherlandsDepartment of Pathology, VU University Medical Center, Amsterdam, The NetherlandsDept. of Otolaryngology, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Hospital Central de Asturias, Oviedo, SpainDepartment of Oncogenesis, Biophysics and Cytometry, National Institute for Cancer Research, Genoa, ItalyDepartment of Tumor Biology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USADepartment of Epidemiology, Nutrition and Toxicology, Research Institute NUTRIM, University Maastricht, The NetherlandsDepartment of Pathology, Research Institute GROW, University Maastricht, The NetherlandsDepartment of Pathology, VU University Medical Center, Amsterdam, The NetherlandsDepartment of Pathology, Research Institute GROW, University Maastricht, The NetherlandsBackground: Colorectal cancers are characterized by genetic and epigenetic alterations. This study aimed to explore the timing of promoter methylation and relationship with mutations and chromosomal alterations in colorectal carcinogenesis. Methods: In a series of 47 nonprogressed adenomas, 41 progressed adenomas (malignant polyps), 38 colorectal carcinomas and 18 paired normal tissues, we evaluated promoter methylation status of hMLH1, O6MGMT, APC, p14ARF, p16INK4A, RASSF1A, GATA-4, GATA-5, and CHFR using methylation-specific PCR. Mutation status of TP53, APC and KRAS were studied by p53 immunohistochemistry and sequencing of the APC and KRAS mutation cluster regions. Chromosomal alterations were evaluated by comparative genomic hybridization. Results: Our data demonstrate that nonprogressed adenomas, progressed adenomas and carcinomas show similar frequencies of promoter methylation for the majority of the genes. Normal tissues showed significantly lower frequencies of promoter methylation of APC, p16INK4A, GATA-4, and GATA-5 (P-values: 0.02, 0.02, 1.1×10−5 and 0.008 respectively). P53 immunopositivity and chromosomal abnormalities occur predominantly in carcinomas (P values: 1.1×10−5 and 4.1×10−10). Conclusions: Since promoter methylation was already present in nonprogressed adenomas without chromosomal alterations, we conclude that promoter methylation can be regarded as an early event preceding TP53 mutation and chromosomal abnormalities in colorectal cancer development.http://dx.doi.org/10.1155/2006/846251
spellingShingle Sarah Derks
Cindy Postma
Peter T. M. Moerkerk
Sandra M. van den Bosch
Beatriz Carvalho
Mario A. J. A. Hermsen
Walter Giaretti
James G. Herman
Matty P. Weijenberg
Adriaan P. de Bruïne
Gerrit A. Meijer
Manon van Engeland
Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
Cellular Oncology
title Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
title_full Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
title_fullStr Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
title_full_unstemmed Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
title_short Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
title_sort promoter methylation precedes chromosomal alterations in colorectal cancer development
url http://dx.doi.org/10.1155/2006/846251
work_keys_str_mv AT sarahderks promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT cindypostma promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT petertmmoerkerk promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT sandramvandenbosch promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT beatrizcarvalho promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT marioajahermsen promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT waltergiaretti promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT jamesgherman promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT mattypweijenberg promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT adriaanpdebruine promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT gerritameijer promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
AT manonvanengeland promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment